OTC Markets OTCPK - Delayed Quote USD
HLS Therapeutics Inc. (HLTRF)
3.4400
+3.4400
(0.00%)
At close: May 2 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 120.5k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.24 per share. | Direct | 19,086 | Mar 31, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 31, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.26 per share. | Direct | 10,090 | Mar 28, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 28, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.12 per share. | Direct | 8,945 | Mar 27, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 27, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.15 per share. | Direct | 10,923 | Mar 26, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 26, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.16 per share. | Direct | 18,241 | Mar 25, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 25, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.26 per share. | Direct | 25,955 | Mar 24, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 24, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.29 per share. | Direct | 26,241 | Mar 21, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 21, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.27 per share. | Direct | 20,286 | Mar 20, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 20, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 2.90 per share. | Direct | 15,633 | Mar 19, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 19, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 2.88 per share. | Direct | 13,819 | Mar 18, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 18, 2025 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 2.80 per share. | Direct | 6,997 | Mar 17, 2025 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | Mar 17, 2025 |
| Beauchamp (Norma) Director of Issuer | Acquisition or disposition in the public market at price 2.73 per share. | Direct | 1,363 | Dec 24, 2024 |
| Welborn (John Lee Jr.,) Director of Issuer | Acquisition or disposition in the public market at price 2.29 per share. | Direct | 4,800 | Dec 12, 2024 |
| Beauchamp (Norma) Director of Issuer | Acquisition or disposition in the public market at price 2.36 per share. | Direct | 1,177 | Nov 14, 2024 |
| Hanna, John Gordon Director of Issuer | Acquisition or disposition in the public market at price 2.33 per share. | Direct | 2,791 | Aug 14, 2024 |
| Hanna, John Gordon Director of Issuer | Acquisition or disposition in the public market at price 2.33 per share. | Direct | 6,518 | Aug 13, 2024 |
| Millian (Craig Stuart) Director of Issuer | Acquisition or disposition in the public market at price 2.90 per share. | Direct | 7,250 | May 15, 2024 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.06 per share. | Direct | 10,088 | May 10, 2024 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | May 10, 2024 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.38 per share. | Direct | 17,903 | May 9, 2024 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | May 9, 2024 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.48 per share. | Direct | 18,433 | May 8, 2024 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | May 8, 2024 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.45 per share. | Direct | 4,136 | May 7, 2024 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | May 7, 2024 |
| HLS Therapeutics Inc. Issuer | Redemption, retraction, cancelation, repurchase at price 3.48 per share. | Direct | 16,365 | May 6, 2024 |
| HLS Therapeutics Inc. Issuer | -- | Direct | -- | May 6, 2024 |
Related Tickers
SEHCF Sweet Earth Holdings Corporation
0.5320
0.00%
BGLAF BioGaia AB (publ)
9.58
0.00%
NMV.F Captor Capital Corp.
0.2940
0.00%
BIOGY BioGaia AB (publ)
10.81
+10.87%
MJ.CN Maven Brands Inc.
0.0200
0.00%
RAMM.CN RAMM Pharma Corp.
0.0150
0.00%
XTXXF Adastra Holdings Ltd.
0.0378
-82.82%
MJRX.CN Global Health Clinics Ltd.
0.0100
0.00%
VIBEF Vibe Growth Corporation
0.0460
-8.00%
CANQF CanaQuest Medical Corp.
0.0140
-30.00%